NERON Inc. (Headquarters: Shibuya-ku, Tokyo) is pleased to announce the completion of the β-test product of its “Mental Well-being Gut Microbiome Cocktail,” which is currently under development.

At present, we are conducting verification based on quality control protocols—including viable bacterial count monitoring—together with productivity assessments and safety evaluations. Upon completion of these confirmations, the product will be utilized in demonstration studies both domestically and internationally, thereby accelerating development toward future clinical applications.

Through the innovative development of products leveraging advances in gut microbiomescience, NERON aims to contribute to the improvement of mental health and the enhancement of social well-being.